EUVIMEDEUVIMED entdecken
Open Access

[Expression of Concern] Endosialin/CD248 may be a potential therapeutic target to prevent the invasion and metastasis in osteosarcoma

Yumiko Kondo, Kanya Honoki, Shingo Kishi, Shiori Mori, Rina Fujiwara-Tani, Shinji Tsukamoto, Hiromasa Fujii, Hiroki Kuniyasu, Yasuhito Tanaka

Oncology Letters · 03.07.2026 · 32 (3) · 1-1

DOI: 10.3892/ol.2026.15744 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Letters, online erschienen am 03.07.2026. Verfasst von Yumiko Kondo und 8 weiteren Autor:innen. Der Volltext ist frei in PubMed Central verfügbar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Kondo, Y., Honoki, K., Kishi, S., Mori, S., Fujiwara-Tani, R., Tsukamoto, S., Fujii, H., Kuniyasu, H., & Tanaka, Y. (2026). [Expression of Concern] Endosialin/CD248 may be a potential therapeutic target to prevent the invasion and metastasis in osteosarcoma. Oncology Letters, 32(3), 1-1. https://doi.org/10.3892/ol.2026.15744

Vancouver

Kondo Y, Honoki K, Kishi S, Mori S, Fujiwara-Tani R, Tsukamoto S, et al. [Expression of Concern] Endosialin/CD248 may be a potential therapeutic target to prevent the invasion and metastasis in osteosarcoma. Oncology Letters. 2026;32(3):1-1. doi:10.3892/ol.2026.15744

BibTeX
@article{Kondo2026,
  author = {Kondo, Yumiko and Honoki, Kanya and Kishi, Shingo and Mori, Shiori and Fujiwara-Tani, Rina and Tsukamoto, Shinji and Fujii, Hiromasa and Kuniyasu, Hiroki and Tanaka, Yasuhito},
  title = {[Expression of Concern] Endosialin/CD248 may be a potential therapeutic target to prevent the invasion and metastasis in osteosarcoma},
  journal = {Oncology Letters},
  year = {2026},
  volume = {32},
  number = {3},
  pages = {1--1},
  doi = {10.3892/ol.2026.15744}
}
Kostenlos starten →